2015 HESI Annual Meeting


JUNE 9-12, 2015


The Health and Environmental Sciences Institute (HESI) held its 2015 Annual Meeting on 9-12 June 2015 at the Westin Georgetown, Washington, DC, USA.

The program booklet for the 2015 Annual Meeting is linked below:

Tab 1 – Agenda

Tab 2 – HESI Assembly

Tab 3 – Emerging Issues Session

Tab 4 – About HESI

Tab 5 – Speaker Bios

Tab 6 – Strategic Planning

Tab 7 – Participants

Annual Meeting Presentations:

HESI Annual Meeting 2015: A Year in Review – HESI Executive Director, Syril D Pettit


HESI Annual Meeting 2015: HESI Cardiovascular Safety Committee:  Bridging nonclinical and clinical science for enhanced cardiac safety –  Dr. Brian Berridge


HESI Annual Meeting 2015: HESI Genomics Committee:   New tools for safety assessment:  small RNA biomarkers and an in vivo model for epigenetic effects – Dr. Karol Thompson (FDA)


HESI Annual Meeting 2015: HESI Protein Allergenicity Committee: Practical challenges in biosafety assessment of novel proteins – Dr. Scott McClain (Syngenta Crop Protection)


HESI Annual Meeting 2015: PATC Satellite context talk:  Practical challenges in biosafety assessment – Willy K. Tonui, PhD, RBP, Chief Executive Officer, Kenya National Biosafety Authority


HESI Annual Meeting 2015: Investing in Innovation – Dr. Misti Ushio, Harris Group


HESI Annual Meeting 2015: Clean Water, Enhanced Nutrition, Healthier Populations – Syril Pettit, HESI Executive Director


HESI Annual Meeting 2015: Food Security and Ecosystem Services Speaker – Dr. Segenet Kelemu, Director General, African Insect Science for Food and Health (ICIPE).


HESI Annual Meeting 2015: Global Burden of Disease 2013: Environmental and Occupational Risks, – Dr. Theo Vos –Institute for Health Metrics and Evaluation


Emerging Issues Proposals:

  • Exposure science and big data
  • Safety of stem cell therapeutics
  • Models for Neonatal theapeutics

Emerging Issues Presentations:

Models / Tests to Assess Stem Cells as Therapeutic Agents.  Using Imaging Technology to Evaluate Stem Cell Safety, Mode of Action and Efficacy

Presented by: Dr. Bill Shingleton (GE Healthcare) and Dr. Greg Mullen (Kings College London)

Transforming Exposure Science Through a Strategic Integration of Emerging Technologies and Big Data to Improve Predictive Exposure Capabilities

Presented by: Dr. Rosemary Zaleski (ExxonMobil Biomedical Sciences)

Nonclinical Efficacy and Safety Studies in Support of Neonatal Pediatric Therapeutics Use and Development

Presented by: Dr. Melissa Tassinari (FDA)

Please contact Ms. Cyndi Nobles (cnobles@hesiglobal.org) for additional information.

Contact Us

Health and Environmental Sciences Institute (HESI)

Phone: +1-202-659-8404
Fax: +1-202-659-3859

740 15th Street NW, Suite 600
Washington, DC 20005

Stay Informed

Sign up for our monthly e-newsletter.